Healthy Volunteer Study Clinical Trial
Official title:
A Study to Assess the Effect of Food on the Bioavailability of Obicetrapib and Ezetimibe After Administration of a Fixed-Dose Combination Formulation of Obicetrapib/Ezetimibe, 10 mg/10 mg in Healthy Adult Subjects
This study will assess the effect of food on the bioavailability of obicetrapib and ezetimibe after a single-dose administration of a fixed-dose combination formulation of obicetrapib/ezetimibe, 10 mg/10 mg in healthy adult male and female subjects under fasted and fed conditions.
This is an open-label, single-dose, randomized, two-treatment, two-period, two-sequence crossover relative bioavailability study under fasted and fed conditions. It will assess the effect of food on the bioavailability of obicetrapib and ezetimibe after a single-dose administration of a fixed-dose combination formulation of obicetrapib/ezetimibe, 10 mg/10 mg in healthy adult male and female subjects under fasted and fed conditions. The screening period will be up to 28 days. Patients that are eligible will enter the clinical facility at least 10.5 hours prior to dosing. Depending on their randomization patients will be fed or fasted prior to dosing. They will remain confined for at least 24 hours. After leaving confinement, patients will return to the clinic 9 times for blood draws. At least 56 days after the first dosing, patients will return to the clinic and go through the same process. Those previously fed before dosing will be fasted and those previously fasted will be fed. Patients will return 9 times after their second confinement for additional blood draws. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03270878 -
Glasdegib Absolute Bioavailability Study
|
Phase 1 | |
| Completed |
NCT03777488 -
Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers.
|
Phase 1 | |
| Completed |
NCT03086278 -
A Study of AST-008 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04711187 -
Study of AT-527 in Healthy Subjects (R07496998)
|
Phase 1 | |
| Completed |
NCT06141889 -
Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05154123 -
Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)
|
Phase 1 | |
| Completed |
NCT05179421 -
Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain
|
Phase 2 | |
| Completed |
NCT03945344 -
Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
|
Phase 1 | |
| Recruiting |
NCT05881993 -
Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects
|
Early Phase 1 | |
| Completed |
NCT04242953 -
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
|
Phase 1 | |
| Completed |
NCT02393950 -
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00866385 -
AZD8566 Food Effect/Microtracer Study
|
Phase 1 | |
| Completed |
NCT04784000 -
Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527
|
Phase 1 | |
| Completed |
NCT01609218 -
A Study of LY2140023 in Healthy Participants
|
Phase 1 | |
| Completed |
NCT02503085 -
Ibuprofen Suspension Bioequivalence Study
|
Phase 1 | |
| Completed |
NCT05004415 -
Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)
|
Phase 1 | |
| Completed |
NCT02256423 -
A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01425450 -
Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05731843 -
Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
|
Phase 1 | |
| Completed |
NCT03031535 -
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
|
Phase 1 |